AIM ImmunoTech (NYSE:AIM) Given New $1.00 Price Target at Maxim Group
AIM ImmunoTech (NYSE:AIM – Free Report) had its target price reduced by Maxim Group from $2.00 to $1.00 in a report published on Tuesday, Benzinga reports. They currently have a buy rating on the stock. Separately, Ascendiant Capital Markets cut their price target on shares of AIM ImmunoTech from $5.25 to $5.00 and set a […]
26 Oct 07:27 · The Markets Daily